The diagnosis of multiple sclerosis and the clinical subtypes

Annals of Indian Academy of Neurology

Volumn 12, Issue 4, 2009, Pages 226-230

  Hurwitz, Barrie J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical subtypes; Diagnosis; Diagnostic criteria; Multiple Sclerosis

Indexed keywords

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID CYTOLOGY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISEASE BY BODY FUNCTION; RECURRENT DISEASE; REVIEW;

EID: 72949083464     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.58276     Document Type: Review

References (28)

1. Ebers GC, Sadovick AD. Epidemiology. In: Multiple sclerosis. In: Paty DW, Ebers GC, editors. Philadelphia: Davis FA; 1998. p. 16.
2. National MS society. Available from: http://www.nationalmssociety. org. accessed on 19-03-09.
3. Compston A, Coles A, Multiple sclerosis. Lancet 2002;359:1221-1231
4. Birnbaum G. Making the diagnosis of multiple sclerosis. Adv Neurol 2006;98:111-124
5. Ebers GC. Natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;17:ii16-9.
6. Schumaker GA, Beebe G, Kilber RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis Ann NY Acad Sci 1965;122:552-568
7. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231
8. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127
9. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the .McDonald Criteria. Ann Neurol 2005;58:840-846
10. Miller D, Compston A. The differential diagnosis of multiple sclerosis. In: McAlpine.s Multiple Sclerosis, 4th ed. Compston A, Confavreux C, Lassman H, McDonald I, Miller D, Noseworthy J, et al, editors. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 389-437.
11. Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: Outcomes and role of magnetic resonance imaging in referral. Arch Neurol 2005;62:585-590
12. Brex PA, Cicarelli O, O.Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164
13. Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Arch Ophthalmol 2003;121:944-949
14. Tintore M, Riviera A, Rio J, Nos C, Grivé E, Téllez N, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67:968-972
15. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898-904.
16. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernández O, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomized study. Lancet 2002;359:1221-1231
17. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242-1249
18. Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, Brochet B, et al. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008;79:195-198
19. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology 2009;72:800-805
20. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: A multicentre retrospective study. Lancet Neurol 2007;6:677-686
21. Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830-833
22. Polman CH. Early diagnosis of multiple sclerosis-still a challenge? Multiple Sclerosis 2008;14:2-3.
23. Hawkins SA, McDonald GV. Benign multiple sclerosis? Clinical course, long term follow-up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999;67:148-152
24. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of .benign. multiple sclerosis at 20 years. Neurology 2007;68:496-500.
25. Nielson JM, Korteweg T, Polman CH. Diagnosing MS: Recent guidelines and future goals focusing on magnetic resonance imaging. Int MSJ 2007;14:29-34.
26. Ford HL, Johnson MH. Telling your patient he/she has multiple sclerosis. Postgrad Med J 1995;71:449-452
27. Heesen C, Kolbeck J, Gold SM, Schulz H, Schulz KH. Delivering the diagnosis of MS- results of a survey among patients and neurologists. Acta Neurol Scand 2003;107:363-368
28. Vitali S. Paraclinical support of the person diagnosed with multiple sclerosis. Int MSJ 2004;11:2-9.